Goselin

Short description:


  • Product Name:Goselin
  • CAS non:65807-02-5
  • Molecular formula:C59h84n18o14
  • Molecular pondus:1269,43 G / mol
  • Sequece:Pyr-His, TRP-Ser, Tyrs-D-Ser (TBU) -Leu-Arg-Pro-Azagly-NH2 Acetate salis
  • Species:albo
  • Package:Secundum mos est scriptor requisitis
  • Application:Advanced Hormone, dependens prostate cancer, provectus hormone, dependens pectus cancer, endometriosis, vteri myoma, uti in generatiua medicina
  • Product Detail

    Product Tags

    Keywords

    Details

    • Proname: Goselin
    • Casno: 65807-02-5
    • Molecular Formula: C59H84N18O14
    • Vultus: Alba Power
    • Application: Advanced Hormone-dependens prostate Ca ...
    • Delivivivivivivivitudine: Promptus Shipment
    • Package: secundum opus tuum
    • Portus: Shenzhen
    • ProductCapacity: II Kilogram / mensis
    • Puritas: XCVIII%
    • PRAECLUSIO: II ~ VIII ℃, protected a lux
    • Translationem: CIF per aerem
    • Limitnum: I Gram

    Excellentia

     

    Professional Goserelin Manufacturer in Sina.
    Qualitas in GMP gradu
    Magna cum competitive pretium
    Noster products includit: bulla peptide apis, medicamine peptide, Custom peptides et VETERINARIUS peptides.

     

    Details

    Molecular formula:

    C59h84n18o14

    Missam relativum Missam:

    1269,43 G / mol

    CAS, Number:

    65807-02-5 (Net), 145781-92-6 (Acetate)

    Long-term repono:

    -20 ± V ° C

    Synonym:

    (D-ser (TBU) VI, Azagly10) -Lhrh

     

    Sequence:

    Pyr-His, TRP-Ser, Tyrs-D-Ser (TBU) -Leu-Arg-Pro-Azagly-NH2 Acetate salis

     

    Agri application:

    Advanced Hormone-dependens prostate cancer
    Advanced Hormone, dependens pectus cancer
    Endometriosis
    Myoma vteri
    Usus in generatiua medicina

     

    Active substantia:

    Goserelin Acetate est potens GNRH (LHRH) Agonist. Post transiens incremento, continua administratio Goselin results in downregulation de LH et FSH campester sequitur per suppressionem ovarii et testicular Steroid Biosynthesis.

    Company Profile:
    Company Name: Shenzhen JMMed Technology Co., Ltd.
    Statutum Year: MMIX
    Capital: 89.5 decies RMB
    Main Product: Oxytocin Acetate, Vasopressin Acetate, Desminin Acetate, Terlipressin Acetate, Caspofungin Acetate, Micafungin Sodium, EPtifibatide Acetate, Bivalin, Liraglutide Acetate, Linaclotide aceteate, degarelix acetate, buserelin acetate, cetrorelix acetate,Goselin acetate, Argirelentia acetate, metus acetate, frangeretur-VIII, ... ..
    Nos contendunt continuing innovations in novam peptide synthesis technology et processus optimization et nostra technica quadrigis habent super decennium ex experientia in peptide synthesis. Jym feliciter summitto multum Anda peptide apis et formulavit products cum CFDA et plus quam quadraginta diebus patents probatus.
    Nostra peptide plant sita est in Nanjing, Jiangsu provinciae et posuit eum a facility of 30,000 quadratum metris in obsequio cum CGMP Guideline. Facultatem facilitatem est audited et inspici ab utroque domesticis et internationalis clients.
    Et sua optimum qualis, summa competitive pretium et fortis technica firmamentum, Jym non solum habet lucrata recognitiones pro sua products ex investigationis organizations et pharmaceutical industries, sed etiam facti sunt unus ex fidelissimis amet in Sinis,. Jym dicata est unum de mundo ducens peptide provisor in proximo futurum.

  • Previous:
  • Next:

  • Scribere nuntium hic mitte nobis
    TOP